in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
U.S. FDA Lifts Import Alert on Dr. Reddy’s API Facility in Mexico
9:52 AM MDT | July 30, 2012 | Deepti Ramesh
Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad, India) says that the U.S. FDA has lifted the import alert on Industrias Químicas Falcon de México, Dr. Reddy’s wholly owned manufacturing facility at Cuernavaca, Mexico. The facility produces intermediates and active pharmaceutical ingredients (APIs). The lifting of the import alert allows Dr. Reddy’s to start importing products into the U.S. from this facility. The Cuernavaca facility received a warning letter from the FDA in June 2011, following an FDA inspection of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee